Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas.
Tuhina KhanNicola RelittiMargherita BrindisiStefania MagnanoDaniela ZistererSandra GemmaStefania ButiniGiuseppe CampianiPublished in: Medicinal research reviews (2019)
Oral squamous cell carcinomas (OSCC) and esophageal squamous cell carcinomas (ESCC) exhibit a survival rate of less than 60% and 40%, respectively. Late-stage diagnosis and lack of effective treatment strategies make both OSCC and ESCC a significant health burden. Autophagy, a lysosome-dependent catabolic process, involves the degradation of intracellular components to maintain cell homeostasis. Targeting autophagy has been highlighted as a feasible therapeutic strategy with clinical utility in cancer treatment, although its associated regulatory mechanisms remain elusive. The detection of relevant biomarkers in biological fluids has been anticipated to facilitate early diagnosis and/or prognosis for these tumors. In this context, recent studies have indicated the presence of specific proteins and small RNAs, detectable in circulating plasma and serum, as biomarkers. Interestingly, the interplay between biomarkers (eg, exosomal microRNAs) and autophagic processes could be exploited in the quest for targeted and more effective therapies for OSCC and ESCC. In this review, we give an overview of the available biomarkers and innovative targeted therapeutic strategies, including the application of autophagy modulators in OSCC and ESCC. Additionally, we provide a viewpoint on the state of the art and on future therapeutic perspectives combining the early detection of relevant biomarkers with drug discovery for the treatment of OSCC and ESCC.
Keyphrases
- squamous cell
- cell death
- endoplasmic reticulum stress
- signaling pathway
- oxidative stress
- drug discovery
- cancer therapy
- high grade
- healthcare
- public health
- mental health
- transcription factor
- risk factors
- single cell
- risk assessment
- climate change
- combination therapy
- current status
- fluorescent probe
- loop mediated isothermal amplification
- bone marrow
- single molecule